168 related articles for article (PubMed ID: 27297129)
21. A genetic score can identify men at high risk for prostate cancer among men with prostate-specific antigen of 1-3 ng/ml.
Nordström T; Aly M; Eklund M; Egevad L; Grönberg H
Eur Urol; 2014 Jun; 65(6):1184-90. PubMed ID: 23891454
[TBL] [Abstract][Full Text] [Related]
22. A genetic risk score is associated with polycystic ovary syndrome-related traits.
Lee H; Oh JY; Sung YA; Chung HW
Hum Reprod; 2016 Jan; 31(1):209-15. PubMed ID: 26573528
[TBL] [Abstract][Full Text] [Related]
23. Reclassification of genetic-based risk predictions as GWAS data accumulate.
Krier J; Barfield R; Green RC; Kraft P
Genome Med; 2016 Feb; 8(1):20. PubMed ID: 26884246
[TBL] [Abstract][Full Text] [Related]
24. Analysis of prostate cancer association with four single-nucleotide polymorphisms from genome-wide studies and serum phyto-estrogen concentrations.
Ho CK; Halley L; Wei J; Habib FK
Prostate Cancer Prostatic Dis; 2012 Dec; 15(4):365-8. PubMed ID: 22733159
[TBL] [Abstract][Full Text] [Related]
25. Association of THADA, FOXP4, GPRC6A/RFX6 genes and 8q24 risk alleles with prostate cancer in Northern Chinese men.
Li XH; Xu Y; Yang K; Shi JJ; Zhang X; Yang F; Yuan H; Zhu X; Zhang YH; Wang JY; Yang Z
J BUON; 2015; 20(5):1223-8. PubMed ID: 26537068
[TBL] [Abstract][Full Text] [Related]
26. Impact of prostate-specific antigen on a baseline prostate cancer risk assessment including genetic risk.
Kader AK; Liss MA; Trottier G; Kim ST; Sun J; Zheng SL; Chadwick K; Lockwood G; Xu J; Fleshner NE
Urology; 2015 Jan; 85(1):165-70. PubMed ID: 25530379
[TBL] [Abstract][Full Text] [Related]
27. Individual and cumulative association of prostate cancer susceptibility variants with clinicopathologic characteristics of the disease.
Bao BY; Pao JB; Lin VC; Huang CN; Chang TY; Lan YH; Lu TL; Lee HZ; Chen LM; Ting WC; Hsieh CJ; Huang SP
Clin Chim Acta; 2010 Sep; 411(17-18):1232-7. PubMed ID: 20450899
[TBL] [Abstract][Full Text] [Related]
28. Assessing the clinical utility of genetic risk scores for targeted cancer screening.
Conran CA; Shi Z; Resurreccion WK; Na R; Helfand BT; Genova E; Zheng SL; Brendler CB; Xu J
J Transl Med; 2021 Jan; 19(1):41. PubMed ID: 33482857
[TBL] [Abstract][Full Text] [Related]
29. Prostate cancer risk-associated variants reported from genome-wide association studies: meta-analysis and their contribution to genetic Variation.
Kim ST; Cheng Y; Hsu FC; Jin T; Kader AK; Zheng SL; Isaacs WB; Xu J; Sun J
Prostate; 2010 Dec; 70(16):1729-38. PubMed ID: 20564319
[TBL] [Abstract][Full Text] [Related]
30. Genetic susceptibility to type 2 diabetes is associated with reduced prostate cancer risk.
Pierce BL; Ahsan H
Hum Hered; 2010; 69(3):193-201. PubMed ID: 20203524
[TBL] [Abstract][Full Text] [Related]
31. Incremental predictive value of 152 single nucleotide polymorphisms in the 10-year risk prediction of incident coronary heart disease: the Rotterdam Study.
de Vries PS; Kavousi M; Ligthart S; Uitterlinden AG; Hofman A; Franco OH; Dehghan A
Int J Epidemiol; 2015 Apr; 44(2):682-8. PubMed ID: 25953786
[TBL] [Abstract][Full Text] [Related]
32. THADA gene polymorphism and prostate cancer risk: a meta-analysis.
Zhao F; Xu Y; Yang K; Liu M; Wei D; Zhang Y; Shi X; Yang F; Wang X; Liang S; Zhao C; Chen X; Sun L; Zhu X; Wang N; Hui J; Zhang Y; Zhu L; Yang Y; Tang L; Wang J; Yang Z
Oncol Res Treat; 2014; 37(3):106-10. PubMed ID: 24685913
[TBL] [Abstract][Full Text] [Related]
33. Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients.
Sun J; Lange EM; Isaacs SD; Liu W; Wiley KE; Lange L; Gronberg H; Duggan D; Carpten JD; Walsh PC; Xu J; Chang BL; Isaacs WB; Zheng SL
Prostate; 2008 Apr; 68(5):489-97. PubMed ID: 18213635
[TBL] [Abstract][Full Text] [Related]
34. Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer.
Setlur SR; Chen CX; Hossain RR; Ha JS; Van Doren VE; Stenzel B; Steiner E; Oldridge D; Kitabayashi N; Banerjee S; Chen JY; Schäfer G; Horninger W; Lee C; Rubin MA; Klocker H; Demichelis F
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):229-39. PubMed ID: 20056642
[TBL] [Abstract][Full Text] [Related]
35. SPINK1 Promoter Variants Are Associated with Prostate Cancer Predisposing Alterations in Benign Prostatic Hyperplasia Patients.
Winchester D; Ricks-Santi L; Mason T; Abbas M; Copeland RL; Beyene D; Jingwi EY; Dunston GM; Kanaan YM
Anticancer Res; 2015 Jul; 35(7):3811-9. PubMed ID: 26124326
[TBL] [Abstract][Full Text] [Related]
36. Association Between the Body Mass Index and Prostate Cancer at Biopsy is Modified by Genetic Risk: A Cross-Sectional Analysis in China.
Zhang GM; Zhu Y; Chen HT; Han CT; Liu F; Xu JF; Ye DW
Medicine (Baltimore); 2015 Oct; 94(42):e1603. PubMed ID: 26496266
[TBL] [Abstract][Full Text] [Related]
37. Polygenic Risk Scores in Prostate Cancer Risk Assessment and Screening.
Byrne L; Toland AE
Urol Clin North Am; 2021 Aug; 48(3):387-399. PubMed ID: 34210493
[TBL] [Abstract][Full Text] [Related]
38. How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis.
Siltari A; Lönnerbro R; Pang K; Shiranov K; Asiimwe A; Evans-Axelsson S; Franks B; Kiran A; Murtola TJ; Schalken J; Steinbeisser C; Bjartell A; Auvinen A;
Clin Genitourin Cancer; 2023 Apr; 21(2):316.e1-316.e11. PubMed ID: 36243664
[TBL] [Abstract][Full Text] [Related]
39. Inherited genetic markers discovered to date are able to identify a significant number of men at considerably elevated risk for prostate cancer.
Sun J; Kader AK; Hsu FC; Kim ST; Zhu Y; Turner AR; Jin T; Zhang Z; Adolfsson J; Wiklund F; Zheng SL; Isaacs WB; Grönberg H; Xu J
Prostate; 2011 Mar; 71(4):421-30. PubMed ID: 20878950
[TBL] [Abstract][Full Text] [Related]
40. Calibration of polygenic risk scores is required prior to clinical implementation: results of three common cancers in UKB.
Wei J; Shi Z; Na R; Resurreccion WK; Wang CH; Duggan D; Zheng SL; Hulick PJ; Helfand BT; Xu J
J Med Genet; 2022 Mar; 59(3):243-247. PubMed ID: 33443076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
